Medical therapy for ulcerative colitis

Niraj Jani, Miguel D. Regueiro

Research output: Contribution to journalArticle

Abstract

Although newer therapeutic agents are being developed for the treatment of inflammatory bowel disease, aminosalicylates and corticosteroids remain the mainstay of treatment for UC (Tables 2-5). Patients who do not respond to these agents or become steroid dependent require immunomodulatory therapy or curative surgery. Cyclosporine represents the greatest treatment advance for UC in 10 years. The role of nicotine, heparin, antibiotics, probiotics, and SCFA in the treatment of UC is less clear, but these agents may offer an alternative therapeutic approach for patients intolerant or nonresponsive to standard therapy.

Original languageEnglish (US)
Pages (from-to)147-166
Number of pages20
JournalGastroenterology Clinics of North America
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Medical therapy for ulcerative colitis'. Together they form a unique fingerprint.

  • Cite this